Global non-interventional study (NIS) to understand the clinical management of difficult to treat patients with locally advanced basal cell carcinoma (LaBCC) - Retrospective medical chart review (2015–2016)
- Grant type:
- Novartis Pharmaceuticals Australia Pty Limited
- Researchers:
-
-
MRFF-NG Practitioner Fellow
Frazer InstituteFaculty of MedicineMRFF-NG Practitioner Fellow
Frazer InstituteFaculty of Medicine
-
- Funded by:
- Novartis Pharmaceuticals Australia Pty Limited
